日本臨床前CRO市場報告（按服務類型（生物分析和DMPK研究、毒理學測試及其他）、最終用戶（生物製藥公司、政府和學術機構、醫療器材公司）和地區分類，2026-2034年）

Japan Preclinical CRO Market Report by Service (Bioanalysis and DMPK Studies, Toxicology Testing, and Others), End Use (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies), and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本臨床前CRO市場規模達2.634億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到5.408億美元，2026年至2034年間的複合年成長率（CAGR）為8.32%。由於各公司更加重視自身核心優勢以及近期在專業治療領域的突破，該市場正呈現強勁的成長動能。

本報告解答的關鍵問題：

日本臨床前CRO市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本臨床前CRO市場產生了哪些影響？
日本臨床前CRO市場依服務類型分類的組成是怎樣的？
日本臨床前CRO市場依最終用途分類的組成是怎樣的？
日本臨床前CRO市場價值鏈的各個階段有哪些？
日本臨床前CRO的關鍵促進因素與挑戰是什麼？
日本臨床前CRO市場的結構是怎麼樣的？主要參與者有哪些？
日本臨床前CRO市場的競爭程度如何？

Japan preclinical CRO market size reached USD 263.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 540.8 Million by 2034, exhibiting a growth rate (CAGR) of 8.32% during 2026-2034. The market is witnessing significant momentum due to a heightened emphasis among companies on their core strengths and recent breakthroughs in specialized treatments.

A preclinical contract research organization (CRO) is a company that delivers diverse research and development (R&D) services to the biotechnology, pharmaceutical, and medical device sectors. These services encompass a wide spectrum, including toxicology investigations, pharmacokinetic assessments, formulation development, regulatory assistance, and pharmacodynamic studies. The applications of preclinical CRO services span various domains, encompassing drug discovery, medical device evaluation, biocompatibility assessments, disease modeling, safety pharmacology investigations, and the selection of appropriate dosage forms. These services facilitate the acceleration of product development, bolster compliance with regulatory requirements, tap into specialized expertise, optimize resource allocation, and offer flexible research solutions.

Japan Preclinical CRO Market Trends:

In the context of the Japanese market, there is an increasing emphasis among companies on concentrating their efforts on their core competencies. This trend is driving the demand for preclinical contract research organizations (CROs) as they enable companies to delegate specialized preclinical tasks, allowing them to allocate more resources to their primary areas of focus, such as late-phase clinical trials or marketing endeavors. Moreover, the surging demand for preclinical CRO services in Japan is linked to the rapid expansion of the pharmaceutical sector in emerging economies, driven by the need to address unique healthcare challenges and cater to a growing patient population. Additionally, the market is benefiting from recent advancements in specialized treatments like personalized medicine, biologics, and gene therapies, which necessitate precise and nuanced preclinical testing. Furthermore, the widespread adoption of preclinical CROs is driven by the desire to adopt a risk-balanced approach, especially in light of the high failure rate in drug development. Lastly, the introduction of cutting-edge technologies that play a pivotal role in the successful execution of preclinical studies is expected to bolster the market's growth prospects in Japan over the forecasted period.

Japan Preclinical CRO Market Segmentation:

Service Insights:

Bioanalysis and DMPK Studies
Toxicology Testing
Others

End Use Insights:

Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan preclinical CRO market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan preclinical CRO market?
What is the breakup of the Japan preclinical CRO market on the basis of service?
What is the breakup of the Japan preclinical CRO market on the basis of end use?
What are the various stages in the value chain of the Japan preclinical CRO market?
What are the key driving factors and challenges in the Japan preclinical CRO?
What is the structure of the Japan preclinical CRO market and who are the key players?
What is the degree of competition in the Japan preclinical CRO market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Preclinical CRO Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Preclinical CRO Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Preclinical CRO Market - Breakup by Service

6.1 Bioanalysis and DMPK Studies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Toxicology Testing
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Others
- 6.3.1 Historical and Current Market Trends (2020-2025)
- 6.3.2 Market Forecast (2026-2034)

7 Japan Preclinical CRO Market - Breakup by End Use

7.1 Biopharmaceutical Companies
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Government and Academic Institutes
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Medical Device Companies
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)

8 Japan Preclinical CRO Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Service
- 8.1.4 Market Breakup by End Use
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Service
- 8.2.4 Market Breakup by End Use
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Service
- 8.3.4 Market Breakup by End Use
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Service
- 8.4.4 Market Breakup by End Use
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Service
- 8.5.4 Market Breakup by End Use
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Service
- 8.6.4 Market Breakup by End Use
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Service
- 8.7.4 Market Breakup by End Use
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Service
- 8.8.4 Market Breakup by End Use
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Preclinical CRO Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Preclinical CRO Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis